These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 14529044)

  • 1. Ultrastructural correlates of synapse withdrawal at axotomized neuromuscular junctions in mutant and transgenic mice expressing the Wld gene.
    Gillingwater TH; Ingham CA; Coleman MP; Ribchester RR
    J Anat; 2003 Sep; 203(3):265-76. PubMed ID: 14529044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age-dependent synapse withdrawal at axotomised neuromuscular junctions in Wld(s) mutant and Ube4b/Nmnat transgenic mice.
    Gillingwater TH; Thomson D; Mack TG; Soffin EM; Mattison RJ; Coleman MP; Ribchester RR
    J Physiol; 2002 Sep; 543(Pt 3):739-55. PubMed ID: 12231635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Axotomy-dependent and -independent synapse elimination in organ cultures of Wld(s) mutant mouse skeletal muscle.
    Parson SH; Ribchester RR; Davie N; Gandhi NP; Malik RQ; Gillingwater TH; Thomson D
    J Neurosci Res; 2004 Apr; 76(1):64-75. PubMed ID: 15048930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activity-dependent degeneration of axotomized neuromuscular synapses in Wld S mice.
    Brown R; Hynes-Allen A; Swan AJ; Dissanayake KN; Gillingwater TH; Ribchester RR
    Neuroscience; 2015 Apr; 290():300-20. PubMed ID: 25617654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Axonal and neuromuscular synaptic phenotypes in Wld(S), SOD1(G93A) and ostes mutant mice identified by fiber-optic confocal microendoscopy.
    Wong F; Fan L; Wells S; Hartley R; Mackenzie FE; Oyebode O; Brown R; Thomson D; Coleman MP; Blanco G; Ribchester RR
    Mol Cell Neurosci; 2009 Dec; 42(4):296-307. PubMed ID: 19683573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential protection of neuromuscular sensory and motor axons and their endings in Wld(S) mutant mice.
    Oyebode OR; Hartley R; Singhota J; Thomson D; Ribchester RR
    Neuroscience; 2012 Jan; 200():142-58. PubMed ID: 22062136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship of neuromuscular synapse elimination to synaptic degeneration and pathology: insights from WldS and other mutant mice.
    Gillingwater TH; Ribchester RR
    J Neurocytol; 2003; 32(5-8):863-81. PubMed ID: 15034273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mislocalization of neuronal mitochondria reveals regulation of Wallerian degeneration and NMNAT/WLD(S)-mediated axon protection independent of axonal mitochondria.
    Kitay BM; McCormack R; Wang Y; Tsoulfas P; Zhai RG
    Hum Mol Genet; 2013 Apr; 22(8):1601-14. PubMed ID: 23314018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wallerian degeneration of injured axons and synapses is delayed by a Ube4b/Nmnat chimeric gene.
    Mack TG; Reiner M; Beirowski B; Mi W; Emanuelli M; Wagner D; Thomson D; Gillingwater T; Court F; Conforti L; Fernando FS; Tarlton A; Andressen C; Addicks K; Magni G; Ribchester RR; Perry VH; Coleman MP
    Nat Neurosci; 2001 Dec; 4(12):1199-206. PubMed ID: 11770485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The neuroprotective factor Wlds does not attenuate mutant SOD1-mediated motor neuron disease.
    Vande Velde C; Garcia ML; Yin X; Trapp BD; Cleveland DW
    Neuromolecular Med; 2004; 5(3):193-203. PubMed ID: 15626820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A rat model of slow Wallerian degeneration (WldS) with improved preservation of neuromuscular synapses.
    Adalbert R; Gillingwater TH; Haley JE; Bridge K; Beirowski B; Berek L; Wagner D; Grumme D; Thomson D; Celik A; Addicks K; Ribchester RR; Coleman MP
    Eur J Neurosci; 2005 Jan; 21(1):271-7. PubMed ID: 15654865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistence of neuromuscular junctions after axotomy in mice with slow Wallerian degeneration (C57BL/WldS).
    Ribchester RR; Tsao JW; Barry JA; Asgari-Jirhandeh N; Perry VH; Brown MC
    Eur J Neurosci; 1995 Jul; 7(7):1641-50. PubMed ID: 7551190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The slow Wallerian degeneration gene in vivo protects motor axons but not their cell bodies after avulsion and neonatal axotomy.
    Adalbert R; Nógrádi A; Szabó A; Coleman MP
    Eur J Neurosci; 2006 Oct; 24(8):2163-8. PubMed ID: 17074042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The neuroprotective factor Wld(s) fails to mitigate distal axonal and neuromuscular junction (NMJ) defects in mouse models of spinal muscular atrophy.
    Kariya S; Mauricio R; Dai Y; Monani UR
    Neurosci Lett; 2009 Jan; 449(3):246-51. PubMed ID: 19010394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synaptic protection in the brain of WldS mice occurs independently of age but is sensitive to gene-dose.
    Wright AK; Wishart TM; Ingham CA; Gillingwater TH
    PLoS One; 2010 Nov; 5(11):e15108. PubMed ID: 21124744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cellular distribution of the Wld s chimeric protein and its constituent proteins in the CNS.
    Fang C; Bernardes-Silva M; Coleman MP; Perry VH
    Neuroscience; 2005; 135(4):1107-18. PubMed ID: 16154290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transgenic mice expressing the Nmnat1 protein manifest robust delay in axonal degeneration in vivo.
    Sasaki Y; Vohra BP; Baloh RH; Milbrandt J
    J Neurosci; 2009 May; 29(20):6526-34. PubMed ID: 19458223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wallerian degeneration, wld(s), and nmnat.
    Coleman MP; Freeman MR
    Annu Rev Neurosci; 2010; 33():245-67. PubMed ID: 20345246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-nuclear Wld(S) determines its neuroprotective efficacy for axons and synapses in vivo.
    Beirowski B; Babetto E; Gilley J; Mazzola F; Conforti L; Janeckova L; Magni G; Ribchester RR; Coleman MP
    J Neurosci; 2009 Jan; 29(3):653-68. PubMed ID: 19158292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid loss of motor nerve terminals following hypoxia-reperfusion injury occurs via mechanisms distinct from classic Wallerian degeneration.
    Baxter B; Gillingwater TH; Parson SH
    J Anat; 2008 Jun; 212(6):827-35. PubMed ID: 18510509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.